https://enveda.com/news/enveda-appoints-christopher-k-porter-mba-jd-as-senior-vice-president-clinical-operations/ 2026-04-21T21:31:41+00:00 https://enveda.com/news/enveda-reports-positive-results-for-env-294-in-a-phase-1b-clinical-trial-of-patients-with-moderate-to-severe-atopic-dermatitis/ 2026-03-31T16:03:00+00:00 https://enveda.com/news/the-most-innovative-biotech-companies-of-2026/ 2026-03-25T18:51:28+00:00 https://enveda.com/news/enveda-advances-third-asset-to-the-clinic-with-us-fda-ind-clearance-and-phase-1-initiation-of-env-6946/ 2026-01-05T17:01:19+00:00 https://enveda.com/news/enveda-announces-us-fda-ind-clearance-and-first-patient-dosed-in-phase-1-trial-of-env-308-a-first-in-class-oral-therapy-for-obesity-appoints-nadeem-sarwar-ph-d-mpharm-mphil-to-lead-metabolic-di/ 2025-12-17T22:51:57+00:00 https://enveda.com/news/enveda-initiates-phase-2-clinical-trials-of-env-294-a-first-in-class-oral-therapy-in-atopic-dermatitis-and-asthma/ 2025-12-17T22:43:20+00:00 https://enveda.com/news/enveda-ceo-reveals-how-it-will-deploy-150m-in-series-d-funding/ 2025-09-16T18:43:41+00:00 https://enveda.com/news/enveda-raises-150-million-to-use-ai-to-develop-drugs-from-nature/ 2025-09-16T18:41:17+00:00 https://enveda.com/news/enveda-gets-new-backing-to-scour-nature-for-promising-compounds/ 2025-09-05T14:04:59+00:00 https://enveda.com/news/enveda-raises-150m-for-drug-development-reaching-unicorn-status/ 2025-09-05T13:54:11+00:00 https://enveda.com/news/enveda-collects-another-150m-for-ii-drug-sprawling-pipeline-of-preclinical-assets/ 2025-09-04T16:11:58+00:00 https://enveda.com/news/enveda-cracking-the-chemical-code-of-life-with-ai/ 2025-09-04T15:39:23+00:00 https://enveda.com/news/enveda-raises-150m-series-d-funding-to-reach-unicorn-status-enrolls-first-patient-in-lead-program-and-adds-mikael-dolsten-to-board-of-directors/ 2025-09-04T14:55:16+00:00 https://enveda.com/news/enveda-biosciences-closes-51m-series-a-financing-led-by-lux-capital/ 2025-09-02T20:09:11+00:00 https://enveda.com/news/enveda-biosciences-closes-68-million-combined-series-b-equity-and-debt-financing/ 2025-09-02T20:06:49+00:00 https://enveda.com/news/enveda-biosciences-announces-oversubscribed-series-b1-bringing-total-round-to-us119-million/ 2025-09-02T20:04:02+00:00 https://enveda.com/news/enveda-biosciences-announces-55m-in-new-funding-to-accelerate-platform-and-advance-multiple-candidates-to-clinical-trials/ 2025-09-02T19:58:34+00:00 https://enveda.com/news/pr-enveda-biosciences-hires-chief-medical-officer-to-advance-its-rich-pipeline-of-therapeutic-programs-into-the-clinic/ 2025-09-02T19:42:28+00:00 https://enveda.com/news/pr-enveda-biosciences-announces-microsoft-collaboration-and-reveals-foundation-model-to-read-and-translate-chemistry/ 2025-09-02T19:41:02+00:00 https://enveda.com/news/enveda-biosciences-unveils-new-ai-algorithm-to-unlock-natures-chemical-code/ 2025-09-02T17:11:37+00:00 https://enveda.com/news/transforming-natural-product-drug-discovery-machine-learning-for-high-fidelity-chemical-property-prediction-from-metabolomics-data/ 2025-09-02T17:09:44+00:00 https://enveda.com/news/enveda-translates-lifes-chemistry-into-medicines/ 2025-09-02T17:08:58+00:00 https://enveda.com/news/enveda-raises-55m-to-combine-ancient-remedies-with-ai-for-drug-discovery/ 2025-09-02T17:05:35+00:00 https://enveda.com/news/ai_challenger_enveda/ 2025-06-24T17:13:56+00:00 https://enveda.com/news/enveda-reports-favorable-phase-1-safety-for-novel-oral-anti-inflammatory-launches-phase-1b-trial-in-atopic-dermatitis/ 2025-05-28T17:03:57+00:00 https://enveda.com/news/americas-greatest-startup-workplaces-2025/ 2025-03-27T16:26:02+00:00 https://enveda.com/news/2025-americas-best-startup-employers/ 2025-03-27T16:25:14+00:00 https://enveda.com/news/enveda-welcomes-jason-kim-as-chief-financial-officer/ 2025-03-26T20:48:41+00:00 https://enveda.com/news/enveda-expands-into-asthma-with-first-in-class-lead-asset-env-294-and-assembles-world-class-advisory-board/ 2025-03-26T20:45:32+00:00 https://enveda.com/news/enveda-gains-backing-from-sanofi-to-advance-ai-driven-drug-discovery-to-clinical-trials-bringing-total-series-c-financing-to-150m/ 2025-03-26T20:44:21+00:00 https://enveda.com/news/ai-drug-discovery-startup-enveda-raises-130-million/ 2024-11-21T15:06:15+00:00 https://enveda.com/news/enveda-closes-130m-series-c-funding-to-deliver-multiple-clinical-readouts-from-a-pipeline-of-10-development-candidates/ 2024-11-21T15:05:26+00:00 https://enveda.com/news/enveda-announces-first-candidate-discovered-from-nature-using-ai-advances-to-clinical-trials-2/ 2024-11-13T17:07:02+00:00